The WHI ten year's later: An epidemiologist's view

Journal of Steroid Biochemistry and Molecular Biology

Volumn 142, Issue , 2014, Pages 12-15

  Lacey, James V ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Observational study; Randomized clinical trial; Study design; Timing hypothesis

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

CHRONIC DISEASE; CLIMACTERIUM; CONSENSUS; EARLY TERMINATION OF CLINICAL TRIAL; HORMONAL THERAPY; HUMAN; POSTMENOPAUSE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR;

EPIDEMIOLOGY; OBSERVATIONAL STUDY; RANDOMIZED CLINICAL TRIAL; STUDY DESIGN; TIMING HYPOTHESIS;

ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; POSTMENOPAUSE; RESEARCH DESIGN; WOMEN'S HEALTH;

EID: 84899886361     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.08.006     Document Type: Review

References (6)

1. R.L. Prentice, and G.L. Anderson The women's health initiative: lessons learned Annu. Rev. Public Health 29 2008 131 150
2. R.L. Prentice, R. Langer, M.L. Stefanick, B.V. Howard, M. Pettinger, and G. Anderson et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial Am. J. Epidemiol. 162 September (5) 2005 404 414
3. R.L. Prentice, R.D. Langer, M.L. Stefanick, B.V. Howard, M. Pettinger, and G.L. Anderson et al. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease Am. J. Epidemiol. 163 April (7) 2006 589 599
4. R.L. Prentice, R.T. Chlebowski, M.L. Stefanick, J.E. Manson, R.D. Langer, and M. Pettinger et al. Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study Am. J. Epidemiol. 167 June (12) 2008 1407 1415
5. C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton, and R. Hoover Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk JAMA 283 January (4) 2000 485 491
6. R.K. Ross, A. Paganini-Hill, P.C. Wan, and M.C. Pike Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin J. Natl. Cancer Inst. 92 February (4) 2000 328 332